Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-05-26
1993-08-17
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 68, C07D41306, A61K 31535
Patent
active
052369161
ABSTRACT:
Novel compounds having the formula ##STR1## wherein X, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agents.
REFERENCES:
J. H. Freeman et al., "1,2,4-Benzothiadiazine Dioxides and 3,4-Dihydro-3,4-Dihydro-1,2,4-Benzothiadiazine Dioxides", J. Org. Chem. 16, 815 (1951).
K. S. Atwal et al., "Substituted 1,4-Dihydropyrimidines, 3. Synthesis of Selectively Functionalized 2-Hetero-1,4-dihydropyrimidines", J. Org. Chem. 54, 25 (1989), pp. 5898-5907.
Poss Michael A.
Weller, III Harold N.
E. R. Squibb & Sons Inc.
Ford John M.
Park Ellen K.
LandOfFree
Oxadiazinone substituted indole and benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxadiazinone substituted indole and benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxadiazinone substituted indole and benzimidazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243824